List of fellows of the AACR Academy

Last updated June 15, 2024

The American Association for Cancer Research elects classes of fellows to recognize influential scientists in the field of cancer research.

Six fellows were appointed to Vice President Biden’s Cancer Moonshot Initiative Blue Ribbon Panel. Several are members of the National Academy of Sciences, several have won a Lasker Award, several have won a Nobel Prize, several are HHMI Investigators, and several are past presidents of the AACR.^[1]^[2]^[3]^[4]^[5]

Year elected	Name	Institution
2013	Karen H. Antman, MD	Boston University School of Medicine
2013	David Baltimore, PhD	California Institute of Technology
2013	Françoise Barré-Sinoussi, PhD	Institute Pasteur
2013	Paul Berg, PhD	Stanford University School of Medicine
2013	Joseph R. Bertino, MD	The Cancer Institute of New Jersey/Robert Wood Johnson Medical School
2013	J. Michael Bishop, MD	University of California, San Francisco
2013	Mina Bissell, PhD	Lawrence Berkeley National Laboratory
2013	Elizabeth Blackburn, PhD	Salk Institute
2013	Sydney Brenner, MBChB, DPhil	Deceased (1927-2019)
2013	Angela Hartley Brodie, PhD	Deceased (1934-2017)
2013	Mario R. Capecchi, PhD	University of Utah
2013	Webster K. Cavenee, PhD	Ludwig Institute for Cancer Research, University of California San Diego
2013	Martin Chalfie, PhD	Columbia University
2013	Zhu Chen, MD, PhD	National People's Congress
2013	Aaron J. Ciechanover, DSc, MD	Technion-Israel Institute of Technology
2013	Bayard D. Clarkson, MD	Memorial Sloan Kettering Cancer Center
2013	Donald S. Coffey, PhD	Deceased (1932-2017)
2013	Stanley N. Cohen, MD	Stanford University School of Medicine
2013	Suzanne Cory, PhD	Walter & Eliza Hall Institute of Medical Research; University of Melbourne
2013	Carlo M. Croce, MD	Ohio State University Comprehensive Cancer Center
2013	Tom Curran, PhD	Children's Mercy Hospital
2013	Brian J. Druker, MD	Oregon Health & Science University Knight Cancer Institute
2013	Raymond N. DuBois, MD, PhD	Medical University of South Carolina
2013	Martin J. Evans, PhD	Cardiff University
2013	Emmanuel Farber, MD, PhD	Deceased (1918-2014)
2013	Napoleone Ferrara, MD	Moores Cancer Center; University of California San Diego Moores Cancer Center
2013	Isaiah J. Fidler, DVM, PhD	University of Texas MD Anderson Cancer Center
2013	Bernard Fisher, MD	Deceased (1918-2019)
2013	Joseph F. Fraumeni Jr., MD	National Cancer Institute, National Institutes of Health
2013	Emil Frei, MD	Deceased (1924-2013)
2013	Elaine Fuchs, PhD	Rockefeller University
2013	Judy E. Garber, MD, MPH	Center for Cancer Genetics and Prevention, Dana–Farber Cancer Institute
2013	Walter Gilbert, PhD	BioVentures Investors
2013	Alfred G. Gilman, MD, PhD	Deceased (1941-2015)
2013	Carol W. Greider, PhD	Johns Hopkins University School of Medicine
2013	Roger C. L. Guillemin, MD, PhD	The Salk Institute for Biological Studies
2013	John B. Gurdon, DPhil	The Wellcome Trust; Cancer Research UK Gurdon Institute
2013	William N. Hait, MD, PhD	Janssen Research & Development, LLC
2013	Leland H. Hartwell, PhD	Arizona State University Biodesign Institute
2013	Avram Hershko, MD, PhD	Technion-Israel Institute of Technology
2013	James F. Holland, MD	Deceased (1928-2017)
2013	Jimmie C. Holland, MD	Deceased (1925-2018)
2013	Waun Ki Hong, MD	Deceased (1942-2019)
2013	Leroy E. Hood, MD, PhD	Institute for Systems Biology
2013	H. Robert Horvitz, PhD	Massachusetts Institute of Technology
2013	Susan Band Horwitz, PhD	Albert Einstein College of Medicine
2013	R. Timothy Hunt, PhD	Formerly affiliated with Cancer Research UK
2013	Tony Hunter, PhD	Salk Institute
2013	Tyler Jacks, PhD	David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology
2013	Peter A. Jones, DSc, PhD	Van Andel Research Institute
2013	V. Craig Jordan, DSc, PhD	University of Texas MD Anderson Cancer Center
2013	Y. W. Kan, DSc, MD	University of California, San Francisco
2013	Mary-Claire King, PhD	University of Washington School of Medicine
2013	Eva Klein, MD, PhD	Karolinska Institute
2013	George Klein, MD, PhD	Deceased (1925-2016)
2013	Alfred G. Knudson Jr., MD, PhD	Deceased (1922-2016)
2013	Brian K. Kobilka, MD	Stanford University School of Medicine
2013	Margaret L. Kripke, PhD	University of Texas MD Anderson Cancer Center
2013	Philip Leder, MD	Deceased (1934-2019)
2013	Robert J. Lefkowitz, MD	Duke University Medical Center
2013	Arnold J. Levine, PhD	Institute for Advanced Study
2013	Lawrence A. Loeb, MD, PhD	University of Washington School of Medicine
2013	Tak W. Mak, PhD	Princess Margaret Cancer Centre, University of Toronto
2013	Lynn M. Matrisian, PhD	Pancreatic Cancer Action Network
2013	Frank McCormick, PhD	University of California, San Francisco
2013	John Mendelsohn, MD	Deceased (1936-2019)
2013	Donald Metcalf, MD	Deceased (1929-2014)
2013	Enrico Mihich, MD	Deceased (1928-2016)
2013	Beatrice Mintz, PhD	Fox Chase Cancer Center
2013	Luc Montagnier, MD	Pasteur Institute
2013	Harold L. Moses, MD	Vanderbilt-Ingram Cancer Center
2013	Paul M. Nurse, PhD	Francis Crick Institute
2013	Olufunmilayo I. Olopade, MD	University of Chicago Pritzker School of Medicine
2013	Arthur B. Pardee, PhD	Deceased (1921-2019)
2013	Martine J. Piccart, MD, PhD	Institute Jules Bordet
2013	Bruce A.J. Ponder, PhD	Cancer Research UK Cambridge Research Institute
2013	Richard J. Roberts, PhD	New England Biolabs, Inc.
2013	Irwin A. Rose, PhD	Deceased (1926-2015)
2013	Janet D. Rowley, MD	Deceased (1925-2013)
2013	Frederick Sanger, PhD	Deceased (1918-2013)
2013	Alan C. Sartorelli, PhD	Deceased (1931-2015)
2013	Andrew V. Schally, PhD	University of Miami
2013	Phillip A. Sharp, PhD	Massachusetts Institute of Technology
2013	Charles J. Sherr, MD, PhD	St. Jude Children's Research Hospital
2013	Osamu Shimomura, PhD	Deceased (1928-2018)
2013	Dennis J. Slamon, MD, PhD	University of California Los Angeles
2013	Oliver Smithies, DPhil	Deceased (1925-2017)
2013	Michael B. Sporn, MD	Geisel School of Medicine at Dartmouth
2013	Louise C. Strong, MD	University of Texas MD Anderson Cancer Center
2013	Takashi Sugimura, MD	Toho University; National Cancer Center
2013	John E. Sulston, PhD	Deceased (1942-2018)
2013	Jack W. Szostak, PhD	Massachusetts General Hospital
2013	Roger Y. Tsien, PhD	Deceased (1952-2016)
2013	Arthur C. Upton, MD	Deceased (1923-2015)
2013	George F. Vande Woude, Ph	Van Andel Research Institute
2013	Bert Vogelstein, MD	Ludwig Center for Cancer Genetics and Therapeutics; Johns Hopkins University School of Medicine
2013	Peter K. Vogt, PhD	The Scripps Research Institute
2013	Daniel D. Von Hoff, MD	Translational Genomics Research Institute
2013	Geoffrey M. Wahl, PhD	The Salk Institute for Biological Studies
2013	James D. Watson, DSc, PhD	Cold Spring Harbor Laboratory
2013	Lee W. Wattenberg, MD	Deceased (1921-2014)
2013	Robert A. Weinberg, PhD	Ludwig Center for Molecular Oncology; Massachusetts Institute of Technology
2013	John H. Weisburger, PhD	Deceased (1921-2014)
2013	Jane Cooke Wright, MD	Deceased (1919-2013)
2013	Shinya Yamanaka, MD, PhD	University of California San Francisco
2013	Harald zur Hausen, DSc, MD	German Cancer Research Center
2014	Jerry Adams, PhD	Walter and Eliza Hall Institute of Medical Research
2014	James P. Allison, PhD	University of Texas MD Anderson Cancer Center
2014	Mariano Barbacid, PhD	Centro Nacional de Investigaciones Oncologicas
2014	Jose Baselga, MD, PhD	Memorial Sloan Kettering Cancer Center
2014	Stephen B. Baylin, MD	Johns Hopkins Kimmel Cancer Center
2014	Günter Blobel, MD, PhD	Deceased (1936-2018)
2014	David Botstein, PhD	Princeton University, Calico
2014	Joan Brugge, PhD	Harvard Medical School
2014	Lewis C. Cantley, PhD	Weill Cornell Medical College
2014	Pierre Chambon, MD	University of Strasbourg
2014	Hans Clevers, MD, PhD	University of Utrecht
2014	James E. Darnell Jr., MD	The Rockefeller University
2014	Titia de Lange, PhD	The Rockefeller University
2014	Vincent T. DeVita Jr., MD	Yale Medical School
2014	Lawrence H. Einhorn, MD	Indiana University School of Medicine
2014	Stephen J. Elledge, PhD	Brigham and Women’s Hospital
2014	Ronald M. Evans, PhD	Salk Institute for Biological Studies
2014	Andrew Fire, PhD	Stanford University School of Medicine
2014	Emil J. Freireich, MD	University of Texas MD Anderson Cancer Center
2014	Robert C. Gallo, MD	University of Maryland School of Medicine
2014	Douglas Hanahan, PhD	Swiss Institute for Experimental Cancer Research
2014	Richard O. Hynes, PhD	Massachusetts Institute of Technology
2014	William Kaelin, Jr., MD	Dana–Farber Cancer Institute Harvard Medical School
2014	Kenneth W. Kinzler, PhD	Johns Hopkins Kimmel Cancer Center
2014	Richard Kolodner, PhD	Ludwig Institute for Cancer Research
2014	Ronald Levy, MD	Stanford University School of Medicine
2014	Frederick Pei Li, MD	Deceased (1940-2015)
2014	David M. Livingston, MD	Dana–Farber Cancer Institute
2014	Paul A. Marks, MD	Memorial Sloan Kettering Cancer Center
2014	Peter Nowell, MD	Deceased (1928-2016)
2014	Christiane Nüsslein-Volhard, PhD	Max Planck Institute for Developmental Biology
2014	Sir Richard Peto, FRS	University of Oxford
2014	Charles L. Sawyers, MD	Memorial Sloan Kettering Cancer Center
2014	Sir Michael Stratton, MBBS, PhD	Wellcome Trust Sanger Institute
2014	Axel Ullrich, PhD	Max Planck Institute of Biochemistry
2014	Inder Verma, PhD	Salk Institute for Biological Sciences
2014	Irving Weissman, MD	Stanford University School of Medicine
2014	Owen Witte, MD	University of California, Los Angeles
2015	Kenneth C. Anderson, MD	Dana–Farber Cancer Institute
2015	Carlos L. Arteaga, MD	Vanderbilt-Ingram Cancer Center
2015	Anton J.M. Berns, PhD	Netherlands Cancer Institute
2015	Bruce A. Chabner, MD	Massachusetts General Hospital
2015	Ronald A. DePinho, MD	University of Texas MD Anderson Cancer Center
2015	Susan D. Desmond-Hellmann, MD, MPH	Bill & Melinda Gates Foundation
2015	Robert N. Eisenman	Fred Hutchinson Cancer Research Center
2015	Douglas R. Lowy, MD	National Cancer Institute
2015	Carol L. Prives, PhD	Columbia University
2015	Steven A. Rosenberg, MD, PhD	National Cancer Institute
2015	Craig B. Thompson, MD	Memorial Sloan Kettering Cancer Center
2016	Bruce Alberts, PhD	University of California, San Francisco
2016	Clara D. Bloomfield, MD	Deceased (1942-2020)
2016	Thomas R. Cech, PhD	University of Colorado, Boulder
2016	John E. Dick, PhD	University of Toronto
2016	Joe W. Gray, PhD	Oregon Health & Science University
2016	Rudolf Jaenisch, MD	Whitehead Institute for Biomedical Research
2016	Eric S. Lander, PhD	The Broad Institute of MIT and Harvard
2016	Sir David P. Lane, PhD	Ludwig Institute for Cancer Research
2016	Henry T. Lynch, MD	Deceased (1928-2019)
2016	Joan Massagué, PhD	Memorial Sloan Kettering Cancer Center
2016	Joseph Schlessinger, PhD	Yale School of Medicine
2017	Sir Adrian P. Bird, PhD	University of Edinburgh
2017	Emmanuelle Charpentier, PhD	Max Planck Institute for Infection Biology
2017	Riccardo Dalla-Favera, MD	Columbia University
2017	Nancy E. Davidson, MD	University of Washington
2017	Vishva M. Dixit, MD	Genentech
2017	Jennifer A. Doudna, PhD	UC Berkeley
2017	Carl H. June, MD	University of Pennsylvania School of Medicine
2017	Michael Karin, PhD	UC San Diego
2017	Michael B. Kastan, MD, PhD	Duke University School of Medicine
2017	Tomas Lindahl, MD, FRS	Francis Crick Institute
2017	Paul L. Modrich, PhD	Duke University Medical Center
2017	Karen H. Vousden, PhD	Francis Crick Institute
2018	Alan Ashworth, PhD, FRS	University of California, San Francisco
2018	René Bernards, DPhil	Netherlands Cancer Institute
2018	Bruce A. Beutler, MD	UT Southwestern Medical Center
2018	Michael A. Caligiuri, MD	City of Hope National Medical Center
2018	Chi Van Dang, MD, PhD	Ludwig Institute for Cancer Research
2018	Gary Gilliland, MD, PhD	Fred Hutchinson Cancer Research Center
2018	Laurie H. Glimcher, MD	Dana–Farber Cancer Institute
2018	Elizabeth M. Jaffee, MD	Johns Hopkins Kimmel Cancer Center
2018	Richard D. Klausner, MD	Juno Therapeutics
2018	Roger D. Kornberg, PhD	Stanford University School of Medicine
2018	Arthur D. Levinson, PhD	Calico Life Sciences
2018	Norman E. Sharpless, MD	National Cancer Institute
2019	Frederick R. Appelbaum, MD	Fred Hutchinson Cancer Research Center
2019	Dafna Bar-Sagi, PhD	NYU Langone Medical Center
2019	Lisa M. Coussens, PhD	Knight Cancer Institute; Oregon Health & Science University
2019	George Q. Daley, MD, PhD	Harvard Medical School
2019	Gerard Evan, PhD	University of Cambridge
2019	Gordon J. Freeman, PhD	Dana–Farber Cancer Institute
2019	Levi A. Garraway, MD, PhD	Eli Lilly and Company
2019	Melvyn Greaves, PhD	Institute of Cancer Research
2019	Philip D. Greenberg, MD	Fred Hutchinson Cancer Research Center
2019	Daniel Haber, MD, PhD	Harvard Medical School
2019	Jules A. Hoffmann, PhD	University of Strasbourg
2019	Tasuku Honjo, MD, PhD	Kyoto University
2019	Scott W. Lowe, PhD	Memorial Sloan Kettering Cancer Center
2019	Elaine Mardis, PhD	Nationwide Children's Hospital
2019	Larry Norton, MD	Memorial Sloan Kettering Cancer Center
2019	Moshe Oren, PhD	Weizmann Institute of Science
2019	Robert D. Schreiber, PhD	Washington University in St. Louis
2019	Arlene H. Sharpe, MD, PhD	Harvard Medical School
2019	Louis M. Staudt, MD, PhD	National Cancer Institute
2019	Bruce William Stillman, PhD	Cold Spring Harbor Laboratory
2019	Zena Werb, PhD	University of California, San Francisco
2019	Eric F. Wieschaus, PhD	Princeton University
2020	Myles A. Brown, MD	Dana–Farber Cancer Institute; Harvard Medical School
2020	Judith Campisi, PhD	Buck Institute for Research on Aging
2020	Arul Chinnaiyan, MD, PhD	University of Michigan
2020	Alan D. D'Andrea, MD	Dana–Farber Cancer Institute; Harvard Medical School
2020	Mark M. Davis, PhD	Stanford University School of Medicine
2020	Gregory J. Hannon, PhD	University of Cambridge
2020	Rakesh K. Jain, PhD	Harvard Medical School and Massachusetts General Hospital
2020	Maria Jasin, PhD	Memorial Sloan Kettering Cancer Center
2020	Robert S. Langer, ScD	Massachusetts Institute of Technology
2020	Bert W. O'Malley, MD	Baylor College of Medicine
2020	Drew Mark Pardoll, MD, PhD	Johns Hopkins University
2020	Kornelia Polyak, MD, PhD	Harvard Medical School
2020	Peter J. Ratcliffe, FRS	University of Oxford
2020	Antoni Ribas, MD, PhD	University of California Los Angeles Medical Center
2020	Gregg L. Semenza, MD, PhD	Johns Hopkins University School of Medicine
2020	Charles Swanton, MD, PhD	The Francis Crick Institute and University College London Cancer Institute
2020	David A. Tuveson, MD, PhD	Cold Spring Harbor Laboratory Cancer Center
2020	Michael Wigler, PhD	Cold Spring Harbor Laboratory
2020	Sir Gregory Winter, CBE, FRS, FMedSci	Trinity College
2021	Lucile Adams-Campbell, PhD	Georgetown University Medical Center
2021	Frances Arnold, PhD	California Institute of Technology
2021	Allan Balmain, PhD, FRSE, FRS	University of California, San Francisco
2021	Anna D. Barker, PhD	Laurence J. Ellison Institute for Transformative Medicine
2021	Mary C. Beckerle, PhD	University of Utah
2021	Shelley L. Berger, PhD	University of Pennsylvania Perelman School of Medicine
2021	John D. Carpten, PhD	University of Southern California
2021	Lieping Chen, MD, PhD	Yale University School of Medicine
2021	Don W. Cleveland, PhD	University of California, San Diego
2021	Sara A. Courtneidge, PhD	Oregon Health & Science University
2021	Albert de la Chapelle, MD, PhD	deceased
2021	George D. Demetri, MD	Dana-Farber Cancer Institute
2021	Philip C. Hanawalt, PhD	Stanford University
2021	Curtis C. Harris, MD	National Cancer Institute
2021	Nancy H. Hopkins, PhD	Massachusetts Institute of Technology
2021	Guillermina Lozano, PhD	University of Texas MD Anderson Cancer Center
2021	Shigekazu Nagata, PhD	Osaka University
2021	Aviv Rezev, PhD	Genentech, Inc
2021	Martine F. Roussel, PhD	St. Jude Children's Research Hospital
2021	Ton N. Schumacher, PhD	The Netherlands Cancer Institute, Oncode Institute
2021	M. Celeste Simon, PhD	University of Pennsylvania Perelman School of Medicine
2021	Tadatsugu Taniguchi, PhD	The University of Tokyo
2021	Xiaodong Wang, PhD	National Institute of Biological Sciences
2021	Eileen P. White, PhD	Rutgers, The State University Of New Jersey
2021	Yosef Yarden, PhD	Weizmann Institute of Science
2022	Anne-Lise Børresen-Dale, PhD, MD (hc)	University of Oslo
2022	Otis Webb Brawley, MD	Johns Hopkins University
2022	Peter J. Campbell, MBBCh, PhD	Wellcome Sanger Institute
2022	Neal G. Copeland, PhD	The University of Texas MD Anderson Cancer Center
2022	Luis Alberto Diaz Jr., MD	Memorial Sloan Kettering Cancer Center
2022	James R. Downing, MD	St. Jude Children's Research Hospital
2022	Connie J. Eaves, OC, FRSC, FRS, CorrFRSE	British Columbia Cancer Research Center
2022	Denise A. Galloway, PhD	Fred Hutchinson Cancer Center
2022	Patricia A. Ganz, MD	University of California Los Angeles
2022	K. Christopher Garcia, PhD	Stanford University
2022	Jennifer R. Grandis, MD	University of California San Francisco
2022	James R. Heath, PhD	Institute for Systems Biology
2022	Nancy A. Jenkins, PhD	The University of Texas MD Anderson Cancer Center
2022	Thomas J. Kelly, MD, PhD	Memorial Sloan Kettering Cancer Center
2022	Crystal L. Mackall, MD	Stanford University School of Medicine
2022	Alex Matter, MD	Agency for Science, Technology, and Research
2022	Ira Mellman, PhD	Genentech Inc.
2022	Gordon B. Mills, MD, PhD	Oregon Health and Science University
2022	Nikola P. Pavletich, PhD	Memorial Sloan Kettering Cancer Center
2022	Cecil B. Pickett, PhD	Biogen Inc.
2022	Jennifer A. Pietenpol, PhD	Vanderbilt University
2022	Terence H. Rabbitts, FRS, FMedSci	Institute of Cancer Research
2022	Neal Rosen, MD, PhD	Memorial Sloan Kettering Cancer Center
2022	Varda Rotter, PhD	Weizmann Institute of Science
2022	Alexander Y. Rudensky, PhD	Memorial Sloan Kettering Cancer Center
2022	Yang Shi, PhD	Ludwig Institute for Cancer Research
2022	Margaret A. Shipp, MD	Harvard Medical School
2022	Yu Shyr, PhD	Vanderbilt University Medical Center
2022	Maxine F. Singer, PhD	Carnegie Institution for Science
2022	Hamilton O. Smith, MD	J. Craig Venter Institute
2022	Suzanne L. Topalian, MD	Johns Hopkins University School of Medicine
2022	Victor E. Velculescu, MD, PhD	Johns Hopkins University School of Medicine
2022	Jane E. Visvader, PhD	Walter and Eliza Hall Institute of Medical Research
2023	Carolyn R. Bertozzi, PhD	Stanford University
2023	Stephen J. Chanock, MD	National Cancer Institute
2023	George Coukos, MD, PhD	Ludwig Institute for Cancer Research
2023	Hugues de Thé, MD, PhD	College de France
2023	Julian Downward, PhD	The Francis Crick Institute
2023	Laura J. Esserman, MD, MBA	University of California San Francisco
2023	Keith T. Flaherty, MD	Harvard Medical School
2023	P. Andrew Futreal, PhD	The University of Texas MD Anderson Cancer Center
2023	Judy Lieberman, MD, PhD	Harvard Medical School
2023	Patricia M. LoRusso, DO, PhD (hc)	Yale Cancer Center and Smilow Cancer Hospital
2023	Luis F. Parada, PhD	Memorial Sloan Kettering Cancer Center
2023	Dana Pe’er, PhD	Memorial Sloan Kettering Cancer Center
2023	Charles M. Perou, PhD	University of North Carolina Lineberger Comprehensive Cancer Center
2023	Helen Piwnica-Worms, PhD	The University of Texas MD Anderson Cancer Center
2023	Thomas M. Roberts, PhD	Harvard Medical School
2023	Erkki Ruoslahti, MD, PhD	Sanford Burnham Prebys
2023	Michel Sadelain, MD, PhD	Memorial Sloan Kettering Cancer Center
2023	Kevan M. Shokat, PhD	University of California, Berkeley
2023	Andreas Strasser, PhD	Walter and Eliza Hall Institute of Medical Research
2023	Jean Y. J. Wang, PhD	University of California San Diego School of Medicine
2023	Robert A. Winn, MD	Virginia Commonwealth University School of Medicine
2023	Jedd Wolchok, MD, PhD	Weill Medical College of Cornell University
2023	Catherine J. Wu, MD	Harvard University

Related Research Articles

Dana-Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

Emil "Tom" Frei III was an American physician and oncologist. He was the former director and former physician-in-chief of the Dana–Farber Cancer Institute in Boston, Massachusetts. He was also the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019. Glimcher has been at the center of controversies related to animal rights activists, excessive corporate payments, and research misconduct.

Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.

Dana Pe'er, Chair and Professor in Computational and Systems Biology Program at Sloan Kettering Institute is a researcher in computational systems biology. A Howard Hughes Medical Institute (HHMI) Investigator since 2021, she was previously a professor at Columbia Department of Biological Sciences. Pe'er's research focuses on understanding the organization, function and evolution of molecular networks, particularly how genetic variations alter the regulatory network and how these genetic variations can cause cancer.

Richard David Kolodner is an American scientist with Ludwig Cancer Research who has made research contributions to the genetic basis for inherited susceptibility to common cancers. He is a Distinguished Professor of Cellular and Molecular Medicine at the UC San Diego School of Medicine. Kolodner is a member of the National Academy of Sciences and National Academy of Medicine, and he is a fellow of the American Academy of Arts and Sciences.

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Michael A. Caligiuri is an American physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research, the world's largest cancer research organization, for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017), Director of the Comprehensive Cancer Center (2003-2017), and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.

David M. Livingston was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. Dr. Livingston joined the Harvard faculty in 1973. His research focused on breast and ovarian cancer.

Webster K. "Web" Cavenee is the Director of Strategic Alliances in Central Nervous System Cancers at the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California, San Diego. He was the Director of the Ludwig Institute for Cancer Research until 2015 when it was taken over by Richard Kolodner. His laboratory studies gene mutations in cancer, most notably in EGFR and glioblastoma multiforme.

Kenneth C. Anderson is an American hematologist-oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma. He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana–Farber Cancer Institute and is the Kraft Family Professor of Medicine and Vice Chair of the Joint Program in Transfusion Medicine at Harvard Medical School.

Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.

<span class="mw-page-title-main">Daniel Von Hoff</span> American oncologist

Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.

Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.

Dafna Bar-Sagi is a cell biologist and cancer researcher at New York University School of Medicine. She is the Saul J. Farber Professor in the department of biochemistry and molecular pharmacology and the department of medicine and senior vice president and vice dean for science at NYU Langone Health. Bar-Sagi has been a member of scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, and Pancreatic Cancer Action Network.

Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer Research.

Kornelia Polyak is a professor of medicine at Harvard Medical School and an internationally recognized breast cancer expert.

Matthew Langer Meyerson is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.

Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.

Gordon J. Freeman is an American immunologist and oncologist at the Dana-Farber Cancer Institute and Harvard Medical School.

References

↑ "AACR names 2024 fellows of AACR Academy". The Cancer Letter. 2024-01-19. Retrieved 2024-06-14.
↑ "American Association for Cancer Research Announces 2018 Class of Fellows of the AACR Academy". April 3, 2018. Retrieved February 7, 2019.
↑ "Dana–Farber Cancer Institute Faculty Recognized at 2018 AACR Annual Meeting - Dana–Farber Cancer Institute | Boston, MA". www.dana-farber.org. April 19, 2018. Retrieved February 7, 2019.
↑ "AACR announces 2018 class of fellows of AACR Academy – The Cancer Letter". cancerletter.com. 6 April 2018. Retrieved 2020-04-21.
↑ "AACR Announces 2019 Class of Fellows of the AACR Academy - The ASCO Post". www.ascopost.com. Retrieved 2020-04-21.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] "AACR names 2024 fellows of AACR Academy". The Cancer Letter. 2024-01-19. Retrieved 2024-06-14.

[2] "American Association for Cancer Research Announces 2018 Class of Fellows of the AACR Academy". April 3, 2018. Retrieved February 7, 2019.

[3] "Dana–Farber Cancer Institute Faculty Recognized at 2018 AACR Annual Meeting - Dana–Farber Cancer Institute | Boston, MA". www.dana-farber.org. April 19, 2018. Retrieved February 7, 2019.

[4] "AACR announces 2018 class of fellows of AACR Academy – The Cancer Letter". cancerletter.com. 6 April 2018. Retrieved 2020-04-21.

[5] "AACR Announces 2019 Class of Fellows of the AACR Academy - The ASCO Post". www.ascopost.com. Retrieved 2020-04-21.

[1]

[2]

[3]

[4]

[5]